All Phenotypes Pdcd1<tm1Hon> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Pdcd1^tm1Hon
targeted mutation 1, Tasuku Honjo
MGI:2386184

Summary

11 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Pdcd1^tm1Hon/Pdcd1^tm1Hon	B6.129S2-Pdcd1^tm1Hon	MGI:3054644
hm2	Pdcd1^tm1Hon/Pdcd1^tm1Hon	C.129S2(B6)-Pdcd1^tm1Hon	MGI:3054645
hm3	Pdcd1^tm1Hon/Pdcd1^tm1Hon	involves: 129S2/SvPas	MGI:5770299
hm4	Pdcd1^tm1Hon/Pdcd1^tm1Hon	involves: 129S2/SvPas * C57BL/6	MGI:3054643
cx5	Btla^tm1Kmm/Btla^tm1Kmm Pdcd1^tm1Hon/Pdcd1^tm1Hon	B6.129S-Pdcd1^tm1Hon Btla^tm1Kmm	MGI:3706173
cx6	Foxp3^{tm2.1(EGFP/cre)Shori}/Foxp3^{tm2.1(EGFP/cre)Shori} Pdcd1^tm1Hon/Pdcd1^tm1Hon	involves: 129 * 129S2/SvPas * C57BL/6	MGI:5796346
cx7	Foxp3^{tm2.1(EGFP/cre)Shori}/Y Pdcd1^tm1Hon/Pdcd1^tm1Hon	involves: 129 * 129S2/SvPas * C57BL/6	MGI:5796298
cx8	Pdcd1^tm1Hon/Pdcd1^tm1Hon Tg(Tcra2D2,Tcrb2D2)1Kuch/0	involves: 129S2/SvPas	MGI:3814894
cx9	Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Pdcd1^tm1Hon/Pdcd1^tm1Hon	involves: 129S2/SvPas * 129S4/SvJae * BALB/c	MGI:5574062
cx10	Pdcd1^tm1Hon/Pdcd1^tm1Hon Vsir^tm1Lex/Vsir^tm1Lex	involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6	MGI:5770302
cx11	Pdcd1^tm1Hon/Pdcd1^tm1Hon Vsir^tm1Lex/Vsir^tm1Lex Tg(Tcra2D2,Tcrb2D2)1Kuch/0	involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6	MGI:5770303

Allelic Composition	Pdcd1^tm1Hon/Pdcd1^tm1Hon
Genetic Background	B6.129S2-Pdcd1^tm1Hon

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdcd1^tm1Hon mutation (6 available); any Pdcd1 mutation (97 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

autoimmune arthritis ( J:78802 )

• increased layers of synovial tissues in foot joints at 6 months of age

• arthritic lesions more pronounced at 14 months of age

glomerulonephritis ( J:78802 )

• mild proliferative glomerulonephritis at 6 months age

• less than 50% of glomeruli affected

• by 14 months, 50% of mice with a lupus-like glomerulonephritis

abnormal response to transplant ( J:119356 )

• only about 80% of mice show long term MHC class II mismatch allograft survival (Bm12 into B6) compared to about 100% survival in wild-type mice

• however, survival time of MHC class I mismatch allografts is the same as wild-type controls

renal/urinary system

glomerulonephritis ( J:78802 )

• mild proliferative glomerulonephritis at 6 months age

• less than 50% of glomeruli affected

• by 14 months, 50% of mice with a lupus-like glomerulonephritis

skeleton

autoimmune arthritis ( J:78802 )

• increased layers of synovial tissues in foot joints at 6 months of age

• arthritic lesions more pronounced at 14 months of age

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
systemic lupus erythematosus		DOID:9074	OMIM:152700 OMIM:300809 OMIM:605480 OMIM:608437 OMIM:609903 OMIM:609939 OMIM:610065 OMIM:610066 OMIM:612254 OMIM:612378 OMIM:613145 OMIM:614420	J:78802

Allelic Composition	Pdcd1^tm1Hon/Pdcd1^tm1Hon
Genetic Background	C.129S2(B6)-Pdcd1^tm1Hon

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdcd1^tm1Hon mutation (6 available); any Pdcd1 mutation (97 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:66979 )

• start to die around 5 weeks of age, 2/3 are dead by 30 weeks

cardiovascular system

abnormal heart morphology ( J:66979 )

enlarged heart ( J:66979 )

• massively enlarged hearts at death

decreased heart right ventricle wall thickness ( J:66979 )

• thin right venricular wall

dilated heart ventricle ( J:66979 )

• both ventricles dilated to about 2X normal diameter

cardiac fibrosis ( J:66979 )

• sporadic fibrosis and scar formation

abnormal cardiovascular system physiology ( J:66979 )

abnormal cardiac output ( J:66979 )

• impaired pump function of the heart

abnormal cardiac muscle contractility ( J:66979 )

• reduced movement of the ventricular walls and interventricular septum

immune system

increased autoantibody level ( J:66979 )

• higher titers of autoantibodies (IgG1)

• deposition of IgG and C3 complement around cardiomyocytes

liver/biliary system

enlarged liver ( J:66979 )

• varying degrees of hepatomegaly

muscle

abnormal cardiac muscle contractility ( J:66979 )

• reduced movement of the ventricular walls and interventricular septum

vision/eye

exophthalmos ( J:66979 )

• protrusion of eyeballs occurs a few weeks before death

growth/size/body

enlarged heart ( J:66979 )

• massively enlarged hearts at death

enlarged liver ( J:66979 )

• varying degrees of hepatomegaly

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
dilated cardiomyopathy		DOID:12930	OMIM:PS115200	J:66979

Allelic Composition	Pdcd1^tm1Hon/Pdcd1^tm1Hon
Genetic Background	involves: 129S2/SvPas

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdcd1^tm1Hon mutation (6 available); any Pdcd1 mutation (97 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

increased IgA level ( J:222944 )

• moderate in aged mice

increased IgM level ( J:222944 )

• moderate in aged mice

abnormal T cell activation ( J:222944 )

• increased CD44^hiCD62L^lo CD8+ and CD4+ T cells at 6 to 7 months of age

• spontaneous activation of peripheral CD4+ and CD8+ T cells

increased interferon-gamma secretion ( J:222944 )

• on in vitro restimulation of T cells

• when T cells are challenged with antigen

increased inflammatory response ( J:222944 )

• increased leukocyte infiltration with tissue necrosis in several organs including lung, liver and pancreas

endocrine/exocrine glands

pancreas necrosis ( J:222944 )

liver/biliary system

hepatic necrosis ( J:222944 )

respiratory system

pulmonary necrosis ( J:222944 )

hematopoietic system

increased IgA level ( J:222944 )

• moderate in aged mice

increased IgM level ( J:222944 )

• moderate in aged mice

abnormal T cell activation ( J:222944 )

• increased CD44^hiCD62L^lo CD8+ and CD4+ T cells at 6 to 7 months of age

• spontaneous activation of peripheral CD4+ and CD8+ T cells

Allelic Composition	Pdcd1^tm1Hon/Pdcd1^tm1Hon
Genetic Background	involves: 129S2/SvPas * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdcd1^tm1Hon mutation (6 available); any Pdcd1 mutation (97 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

increased B cell proliferation ( J:50688 )

• proliferative response of B cells to anti-IgM is greatly enhanced

enlarged spleen ( J:50688 )

• moderate splenomegaly

abnormal leukopoiesis ( J:50688 )

abnormal myelopoiesis ( J:50688 )

• myeloid lineages in the spleen are also increased

increased lymphocyte cell number ( J:50688 )

• lymphoid cells in the peritoneal cavity increased about 2 fold

increased B cell number ( J:50688 )

• increased numbers of B cells in the spleen

increased B-1 B cell number ( J:50688 )

• B1 cells in the peritoneal cavity are increased

abnormal immunoglobulin level ( J:50688 )

• increased T cell independent antigen responses

• T cell dependent antigen responses were normal

increased IgA level ( J:50688 )

increased IgG2b level ( J:50688 )

• IgG2b levels were increased

increased IgG3 level ( J:50688 )

• IgG3 levels were 3X normal

immune system

increased B cell proliferation ( J:50688 )

• proliferative response of B cells to anti-IgM is greatly enhanced

enlarged spleen ( J:50688 )

• moderate splenomegaly

abnormal leukopoiesis ( J:50688 )

abnormal myelopoiesis ( J:50688 )

• myeloid lineages in the spleen are also increased

increased lymphocyte cell number ( J:50688 )

• lymphoid cells in the peritoneal cavity increased about 2 fold

increased B cell number ( J:50688 )

• increased numbers of B cells in the spleen

increased B-1 B cell number ( J:50688 )

• B1 cells in the peritoneal cavity are increased

abnormal immunoglobulin level ( J:50688 )

• increased T cell independent antigen responses

• T cell dependent antigen responses were normal

increased IgA level ( J:50688 )

increased IgG2b level ( J:50688 )

• IgG2b levels were increased

increased IgG3 level ( J:50688 )

• IgG3 levels were 3X normal

growth/size/body

enlarged spleen ( J:50688 )

• moderate splenomegaly

cellular

increased B cell proliferation ( J:50688 )

• proliferative response of B cells to anti-IgM is greatly enhanced

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
systemic lupus erythematosus		DOID:9074	OMIM:152700 OMIM:300809 OMIM:605480 OMIM:608437 OMIM:609903 OMIM:609939 OMIM:610065 OMIM:610066 OMIM:612254 OMIM:612378 OMIM:613145 OMIM:614420	J:50688

Allelic Composition	Btla^tm1Kmm/Btla^tm1Kmm Pdcd1^tm1Hon/Pdcd1^tm1Hon
Genetic Background	B6.129S-Pdcd1^tm1Hon Btla^tm1Kmm

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Btla^tm1Kmm mutation (3 available); any Btla mutation (30 available)
Pdcd1^tm1Hon mutation (6 available); any Pdcd1 mutation (97 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

increased T cell proliferation ( J:119356 )

• increase in proliferation in response to fully MHC-mismatched stimulation

• increase is decreased by rapamycin treatment

decreased length of allograft survival ( J:119356 )

• decreased survival time of cardiac allografts (source strain Bm12; 10.5 +/- 1.5 days) compared to mice homozygous for the Btla allele alone (14.3 +/- 3.8 days) or wild-type mice (over 100 days)

hematopoietic system

increased T cell proliferation ( J:119356 )

• increase in proliferation in response to fully MHC-mismatched stimulation

• increase is decreased by rapamycin treatment

cellular

increased T cell proliferation ( J:119356 )

• increase in proliferation in response to fully MHC-mismatched stimulation

• increase is decreased by rapamycin treatment

Allelic Composition	Foxp3^{tm2.1(EGFP/cre)Shori}/Foxp3^{tm2.1(EGFP/cre)Shori} Pdcd1^tm1Hon/Pdcd1^tm1Hon
Genetic Background	involves: 129 * 129S2/SvPas * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxp3^{tm2.1(EGFP/cre)Shori} mutation (1 available); any Foxp3 mutation (58 available)
Pdcd1^tm1Hon mutation (6 available); any Pdcd1 mutation (97 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:234397 )

• all females die within 50 days of age

Allelic Composition	Foxp3^{tm2.1(EGFP/cre)Shori}/Y Pdcd1^tm1Hon/Pdcd1^tm1Hon
Genetic Background	involves: 129 * 129S2/SvPas * C57BL/6

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

endocrine/exocrine glands

pancreas atrophy ( J:234397 )

• pancreas is atrophic and the exocrine structure is almost completely lost

pancreas inflammation ( J:234397 )

• early onset of autoimmune exocrine pancreatitis

• total number of cells and frequencies of CD4+ and CD8+ T cells are higher in pancreas and pancreatic lymph nodes

hematopoietic system

enlarged spleen ( J:234397 )

spleen hyperplasia ( J:234397 )

• increased cellularity of spleen

increased effector memory T-helper cell number ( J:234397 )

• increase in CD4+CD44+ and CD8+CD44+ effector/memory T cells, especially in the pancreatic lymph nodes

• increase in frequencies of both CD4+ and CD8+ T cells, especially those expressing CD44 in the spleen and lymph nodes, indicating an expansion of effector/memory T-cell populations

• the ratios of CD4+CD44+/Treg cells and CD8+CD44+/Treg cells are higher, indicating unbalanced T-cell expansion with dominance of effector/memory T cells versus Treg cells

homeostasis/metabolism

decreased circulating lipase level ( J:234397 )

immune system

pancreas inflammation ( J:234397 )

• early onset of autoimmune exocrine pancreatitis

• total number of cells and frequencies of CD4+ and CD8+ T cells are higher in pancreas and pancreatic lymph nodes

enlarged spleen ( J:234397 )

spleen hyperplasia ( J:234397 )

• increased cellularity of spleen

increased effector memory T-helper cell number ( J:234397 )

• increase in CD4+CD44+ and CD8+CD44+ effector/memory T cells, especially in the pancreatic lymph nodes

• increase in frequencies of both CD4+ and CD8+ T cells, especially those expressing CD44 in the spleen and lymph nodes, indicating an expansion of effector/memory T-cell populations

• the ratios of CD4+CD44+/Treg cells and CD8+CD44+/Treg cells are higher, indicating unbalanced T-cell expansion with dominance of effector/memory T cells versus Treg cells

enlarged lymph nodes ( J:234397 )

lymph node hyperplasia ( J:234397 )

• increased cellularity of lymph nodes

increased susceptibility to autoimmune disorder ( J:234397 )

• mice die from T-cell-mediated autoimmune destruction, especially autoimmune pancreatitis

• presence of mononuclear infiltrates in multiple organs such as the pancreas, liver, lung or heart

• more than 70% of neonatal mice that receive CD4+CD25+ T cells from wild-type mice survive over 3 months without any signs of disease

• neonatal mice that receive CD4+CD25+ T cells from Pdcd1^tm1Hon knock-out mice show no signs of disease

mortality/aging

premature death ( J:234397 )

• all males die within 3 months of age

growth/size/body

enlarged spleen ( J:234397 )

spleen hyperplasia ( J:234397 )

• increased cellularity of spleen

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
pancreatitis		DOID:4989	OMIM:167800	J:234397

Allelic Composition	Pdcd1^tm1Hon/Pdcd1^tm1Hon Tg(Tcra2D2,Tcrb2D2)1Kuch/0
Genetic Background	involves: 129S2/SvPas

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdcd1^tm1Hon mutation (6 available); any Pdcd1 mutation (97 available)
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

decreased susceptibility to experimental autoimmune encephalomyelitis ( J:140751 )

• in conjunction with anti-CTLA-4 antibody treatment, mice exhibit reduced paralysis induced by experimental autoimmune encephalomyelitis (EAE) compared to wild type mice

• however, adoptive transfer of Gt(ROSA)26Sor^tm2Awai Cd19^tm1(cre)Cgn double heterozygous B cells increases paralysis induced by EAE despite treatment with anti-CTLA-4 antibodies compared to wild-type mice receiving Gt(ROSA)26Sor^tm2Awai Cd19^tm1(cre)Cgn double heterozygous B cells

Allelic Composition	Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Pdcd1^tm1Hon/Pdcd1^tm1Hon
Genetic Background	involves: 129S2/SvPas * 129S4/SvJae * BALB/c

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fcgr2b^tm1Ttk mutation (7 available); any Fcgr2b mutation (49 available)
Pdcd1^tm1Hon mutation (6 available); any Pdcd1 mutation (97 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

abnormal cytokine level ( J:207275 )

• inflammatory cytokines, including Il2ra, Tnf, Icos, Il1b, Socs1, and Vcam1, are expressed in the suburothelial layer of mice that have anti-urothelial antibodies

abnormal urine cytokine level ( J:207275 )

• urinary cytokines, including GM-CSF, TNF-alpha, IL1-alpha, G-CSF, and IL-1beta, are upregulated in the urine of mice that have anti-urothelial antibodies

increased autoantibody level ( J:207275 )

• anti-urothelial autoantibodies are seen in the serum as early as 7 weeks of age, with about 50% of mice showing autoantibodies at 10 weeks of age

urinary bladder inflammation ( J:207275 )

• mice that are positive for anti-urothelial antibodies show massive infiltration of inflammatory cells at the suburothelial layer

renal/urinary system

abnormal urine cytokine level ( J:207275 )

• urinary cytokines, including GM-CSF, TNF-alpha, IL1-alpha, G-CSF, and IL-1beta, are upregulated in the urine of mice that have anti-urothelial antibodies

urinary bladder inflammation ( J:207275 )

• mice that are positive for anti-urothelial antibodies show massive infiltration of inflammatory cells at the suburothelial layer

abnormal urinary bladder urothelium morphology ( J:207275 )

• mice that are positive for anti-urothelial antibodies show disarrangement of urothelial plaque on the surface of the bladder and disarranged cellular structure of the bladder epithelium at 16 weeks of age

• surface of bladder epithelium shows poorer plaque formation, exposing bare surface of smaller epithelial cells beneath it, in mice that are positive for anti-urothelial antibodies

oliguria ( J:207275 )

• mice that are positive for anti-urothelial antibodies void less urine per void than wild-type mice, even when corrected for body weight

homeostasis/metabolism

abnormal cytokine level ( J:207275 )

• inflammatory cytokines, including Il2ra, Tnf, Icos, Il1b, Socs1, and Vcam1, are expressed in the suburothelial layer of mice that have anti-urothelial antibodies

abnormal urine cytokine level ( J:207275 )

• urinary cytokines, including GM-CSF, TNF-alpha, IL1-alpha, G-CSF, and IL-1beta, are upregulated in the urine of mice that have anti-urothelial antibodies

growth/size/body

decreased body weight ( J:207275 )

• lower body weight in mice that are positive for anti-urothelial antibodies

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
cystitis		DOID:1679		J:207275

Allelic Composition	Pdcd1^tm1Hon/Pdcd1^tm1Hon Vsir^tm1Lex/Vsir^tm1Lex
Genetic Background	involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdcd1^tm1Hon mutation (6 available); any Pdcd1 mutation (97 available)
Vsir^tm1Lex mutation (2 available); any Vsir mutation (26 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

immune system phenotype ( J:222944 )

N	• mice do not develop overt autoimmune disease

increased IgA level ( J:222944 )

• moderate in aged mice

increased IgM level ( J:222944 )

• moderate in aged mice

abnormal T cell activation ( J:222944 )

• increased CD44^hiCD62L^lo CD8+ and CD4+ T cells at 6 to 7 months of age

• spontaneous activation of peripheral CD4+ and CD8+ T cells

increased interferon-gamma secretion ( J:222944 )

• on in vitro restimulation of T cells

• when T cells are challenged with antigen

increased interleukin-17 secretion ( J:222944 )

• on in vitro restimulation of T cells

increased tumor necrosis factor secretion ( J:222944 )

• on in vitro restimulation of T cells

increased inflammatory response ( J:222944 )

• increased leukocyte infiltration with tissue necrosis in several organs including lung, liver and pancreas

endocrine/exocrine glands

pancreas necrosis ( J:222944 )

liver/biliary system

hepatic necrosis ( J:222944 )

respiratory system

pulmonary necrosis ( J:222944 )

hematopoietic system

increased IgA level ( J:222944 )

• moderate in aged mice

increased IgM level ( J:222944 )

• moderate in aged mice

abnormal T cell activation ( J:222944 )

• increased CD44^hiCD62L^lo CD8+ and CD4+ T cells at 6 to 7 months of age

• spontaneous activation of peripheral CD4+ and CD8+ T cells

Allelic Composition	Pdcd1^tm1Hon/Pdcd1^tm1Hon Vsir^tm1Lex/Vsir^tm1Lex Tg(Tcra2D2,Tcrb2D2)1Kuch/0
Genetic Background	involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdcd1^tm1Hon mutation (6 available); any Pdcd1 mutation (97 available)
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation (1 available)
Vsir^tm1Lex mutation (2 available); any Vsir mutation (26 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

increased susceptibility to experimental autoimmune encephalomyelitis ( J:222944 )

• mice exhibit accelerated onset and succumb to complete hindlimb paralysis faster than control mice

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/10/2024 MGI 6.24